Hepatitis C virus (HCV) infection is a major world health problem infecting 170 million people with many chronic HCV carriers at risk of developing liver cirrhosis and liver cancer. There is a strong correlation between chronic HCV infection, low plasma cholesterol levels and steatosis (fatty liver). Little is known about the role of HCV in the pathogenesis of steatosis. Understanding the mechanism of steatosis associated with hepatitis C is relevant to the design of antiviral therapies. In this study, we propose to test the hypothesis that HCV-induced oxidative stress triggers intracellular events, which lead to hepatosteatosis and fibrosis. This hypothesis is strengthened by our recent preliminary results in which we observed accumulation of cholesterol in HCV genotype 1-expressing cells.
The specific aims of this proposal are to: (1) to investigate the mechanism(s) of activation of sterol regulatory element binding proteins (SREBPs) by HCV gene expression and (2) to analyze the effect of HCV gene expression on the major components of the cholesterol and lipid biosynthesis pathways by determining the direct affect of HCV gene expression on the proteins and enzymes involved in cholesterol and lipid biosynthesis. SREBPs are endoplasmic reticulum (ER)-associated proteins, which are cleaved upon sensing low sterols. The liberated proteins then translocate to the nucleus and stimulate genes involved in lipid and fatty acid synthetic pathways. Using the HCV replicon bearing cells, we propose to monitor the activation of SREBP proteins. Using the system we furthe propose to determine the effects of HCV gene expression on the regulation of microsomal trigylceride protein (MTP) and lipid export. To correlate with projects of the center grant, the role of HCV gene expression in altering MTP function and its relevance to CD1d cell surface expression will be investigated. Finally, the conditioned culture supernatants will be tested for their fibrogenic potential via cytokine signaling. These collaborative efforts provide a coherent theme of the center and are likely to offer insight into the mechanisms of liver injury including steatosis associated with chronic HCV infection as well as guide the design of novel therapeutic approaches.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program--Cooperative Agreements (U19)
Project #
5U19AI066313-04
Application #
7575789
Study Section
Special Emphasis Panel (ZAI1)
Project Start
2008-03-01
Project End
2010-02-28
Budget Start
2008-03-01
Budget End
2009-02-28
Support Year
4
Fiscal Year
2008
Total Cost
$160,781
Indirect Cost
Name
Beth Israel Deaconess Medical Center
Department
Type
DUNS #
071723621
City
Boston
State
MA
Country
United States
Zip Code
02215
Kim, Yong Ook; Popov, Yury; Schuppan, Detlef (2017) Optimized Mouse Models for Liver Fibrosis. Methods Mol Biol 1559:279-296
Locatelli, Luigi; Cadamuro, Massimiliano; Spirlì, Carlo et al. (2016) Macrophage recruitment by fibrocystin-defective biliary epithelial cells promotes portal fibrosis in congenital hepatic fibrosis. Hepatology 63:965-82
Jiménez Calvente, Carolina; Sehgal, Alfica; Popov, Yury et al. (2015) Specific hepatic delivery of procollagen ?1(I) small interfering RNA in lipid-like nanoparticles resolves liver fibrosis. Hepatology 62:1285-97
Yang, Liu; Kwon, Junghee; Popov, Yury et al. (2014) Vascular endothelial growth factor promotes fibrosis resolution and repair in mice. Gastroenterology 146:1339-50.e1
Kwong, Gabriel A; von Maltzahn, Geoffrey; Murugappan, Gayathree et al. (2013) Mass-encoded synthetic biomarkers for multiplexed urinary monitoring of disease. Nat Biotechnol 31:63-70
Chowdhury, Sumaiya; Chen, Yiqian; Yao, Tsun-Wen et al. (2013) Regulation of dipeptidyl peptidase 8 and 9 expression in activated lymphocytes and injured liver. World J Gastroenterol 19:2883-93
Yanagisawa, K; Yue, S; van der Vliet, H J et al. (2013) Ex vivo analysis of resident hepatic pro-inflammatory CD1d-reactive T cells and hepatocyte surface CD1d expression in hepatitis C. J Viral Hepat 20:556-65
Schuppan, Detlef; Pinzani, Massimo (2012) Anti-fibrotic therapy: lost in translation? J Hepatol 56 Suppl 1:S66-74
Lynch, Lydia; Nowak, Michael; Varghese, Bindu et al. (2012) Adipose tissue invariant NKT cells protect against diet-induced obesity and metabolic disorder through regulatory cytokine production. Immunity 37:574-87
Li, Shaoyong; Vriend, Lianne E M; Nasser, Imad A et al. (2012) Hepatitis C virus-specific T-cell-derived transforming growth factor beta is associated with slow hepatic fibrogenesis. Hepatology 56:2094-105

Showing the most recent 10 out of 25 publications